Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLC19A3 Inhibition and Thiamine Pharmacokinetics
NCT03746106Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2019
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of thiamine in thiamine deficiency, sponsored by University of California, San Francisco. Started Jan 2019; status: completed.
02
Drugs
thiamine
03
Conditions
thiamine deficiency
Beyond the preview
Go deeper on NCT03746106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746106.